PF-07264660
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-07264660, covering 2024-06-06 to 2026-02-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis [Phase 2]